兔抗LXN多克隆抗體

Background:

Latexin, also designated endogenous carboxypeptidase inhibitor (ECI) or tissue carboxypeptidase inhibitor (TCI), belongs to the protease inhibitor I47 family of proteins. Latexin acts as a non-competitive, reversible inhibitor for metallocarboxypeptidases (MCPs), including CPA1, CPA2 and CPA4. It is a cytoplasmic protein that is highly expressed in heart, prostate, pancreas, ovary, kidney, brain and colon. Latexin consists of two topologically equivalent subdomains that bind to MCPs with low specificity, which gives it with the flexibility to inhibit all vertebrate A/B MCPs.

Applications:

ELISA, WB, IHC

Name of antibody:

LXN

Immunogen:

Fusion protein of human LXN

Full name:

latexin

Synonyms：

ECI; TCI

SwissProt:

Q9BS40

ELISA Recommended dilution:

2000-10000

IHC positive control:

Human thyroid cancer and Human colon cancer

IHC Recommend dilution:

25-100

WB Predicted band size:

26 kDa

WB Positive control:

A549 cells

WB Recommended dilution:

1000-5000